I would be cautious - there are plenty of private clinics already treating patients with psychedelic assisted psychotherapy. I can't see specific advantage here and I would be very surprised if there's further deregulation, given the broad disappointment that met the TGA decision earlier this year.
600 patients is too high in the short term, given how time-intensive treatment is. $5K is definitely too low, so those numbers aren't unachievable but again, be cautious with a very uncertain future.
- Forums
- ASX - By Stock
- IHL
- Ann: IHL-675A Phase 1 Results Presentation
Ann: IHL-675A Phase 1 Results Presentation, page-15
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online